Ashton Thomas Private Wealth’s Quest Diagnostics DGX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Sell	9,353 -17	-0.2%	-$3.34K	0.04%	387
2026 Q1	$1.84M	Buy	9,370 +406	+5%	+$78.9K	0.04%	385
2025 Q4	$1.56M	Buy	8,964 +473	+6%	+$86.1K	0.04%	368
2025 Q3	$1.62M	Buy	8,491 +1,647	+24%	+$292K	0.04%	363
2025 Q2	$1.23M	Buy	6,844 +2,285	+50%	+$397K	0.04%	368
2025 Q1	$771K	Buy	4,559 +383	+9%	+$62.9K	0.03%	445
2024 Q4	$630K	Buy	+4,176	New	+$650K	0.02%	482
2024 Q3	–	Sell	-111	Closed	-$15.3K	–	922
2024 Q2	$15.3K	Buy	+111	New	+$15.2K	﹤0.01%	1223
2020 Q2	–	Sell	-9,951	Closed	-$799K	–	238
2020 Q1	$799K	Buy	+9,951	New	+$1.03M	0.33%	88

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ashton Thomas Private Wealth's DGX Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its Quest Diagnostics (DGX) stake by 0.18% in Q2 2026, selling an estimated $3.34K and leaving 9,353 shares worth $1.98M. The position accounts for 0.04% of the portfolio, ranked #387.

Ashton Thomas Private Wealth first reported a position in DGX in Q1 2020 and has held it in 9 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Ashton Thomas Private Wealth held 9,353 shares of Quest Diagnostics worth $1.98M as of Q2 2026.
Ashton Thomas Private Wealth sold 17 Quest Diagnostics shares in Q2 2026, an estimated $3.34K.
Quest Diagnostics made up 0.04% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #387 holding.
Ashton Thomas Private Wealth first reported a position in Quest Diagnostics in Q1 2020 and has held it in 9 quarters since.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.